Drug intelligence / Profile preview

Shuanghuang Yangxue Decoction

Development stage: Preclinical
Lead developer: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine
Administration: Oral

Overview

Shuanghuang Yangxue Decoction is a Traditional Chinese Medicine (TCM) herbal formula developed for the treatment of cancer-related anemia, specifically in patients with lung cancer and iron deficiency. It is being evaluated in clinical trials sponsored by the Yueyang Hospital of Integrated Traditional Chinese and Western Medicine. The decoction is formulated based on TCM principles to nourish blood and tonify qi, aiming to improve hematological parameters such as hemoglobin levels and serum ferritin. As a decoction, it is prepared by boiling a specific combination of herbs and is administered orally.

Other names: Shuanghuang Yangxue Tang

Targets

EPO (Erythropoietin)

Beyond the preview

Go deeper on Shuanghuang Yangxue Decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shuanghuang Yangxue Decoction.

Explore the full profile